ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
Published: Feb. 25, 2023 at 2:02 PM CST|Updated: 3 hours ago
NEW YORK, Feb. 25, 2023 /PRNewswire/ —
/cloudfront-us-east-1.images.arcpublishing.com/gray/G5M5MO5M3MMRSJPCYAMWAGHPJA.jpg)
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fate Therapeutics, Inc. (NASDAQ: FATE) between April 2, 2020 and January 5, 2023, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move to Court no later than March 22, 2023.
SO WHAT: If you purchased Fate securities during